LONDON--(BUSINESS WIRE)--May 9, 2017--
LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a
market-leading medical technology and innovation company, today
announced Damien McDonald, Chief Executive Officer, will present at the
Bank of America Merrill Lynch (BAML) 2017 Health Care Conference in Las
Vegas and at the Jefferies (Jefferies) 2017 Global Healthcare Conference
in New York City.
The discussion at the BAML conference is scheduled to begin at 9:20 a.m.
Pacific Time on Tuesday, May 16, and the discussion at the Jefferies
conference is scheduled to begin at 3:00 p.m. Eastern Daylight Time on
Thursday, June 8. Both discussions will be available to all interested
parties through a live audiocast accessible via the investor relations
section of LivaNova’s website at http://investor.livanova.com.
Listeners should log on approximately 10 minutes in advance to ensure
proper setup to receive the audiocast. A replay of the webcast will be
available on the LivaNova website approximately 24 hours after the live
presentation for 90 days after the event.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNova’s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
in London and with a presence in more than 100 countries worldwide, the
company employs more than 4,500 employees. LivaNova operates as three
business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm
Management, with operating headquarters in Mirandola (Italy), Houston
(U.S.A.) and Clamart (France), respectively.
For more information, please visit www.livanova.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170509006017/en/
Source: LivaNova PLC
Investor Relations and Media
Karen King, +1-281-228-7262
Vice
President, Investor Relations & Corporate Communications
investor.relations@livanova.com